277 related articles for article (PubMed ID: 27402756)
1. Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation.
Velásquez C; Cheng E; Shuda M; Lee-Oesterreich PJ; Pogge von Strandmann L; Gritsenko MA; Jacobs JM; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8466-71. PubMed ID: 27402756
[TBL] [Abstract][Full Text] [Related]
2. CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.
Shuda M; Velásquez C; Cheng E; Cordek DG; Kwun HJ; Chang Y; Moore PS
Proc Natl Acad Sci U S A; 2015 May; 112(19):5875-82. PubMed ID: 25883264
[TBL] [Abstract][Full Text] [Related]
3. Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E).
Sun R; Cheng E; Velásquez C; Chang Y; Moore PS
J Biol Chem; 2019 Aug; 294(31):11840-11852. PubMed ID: 31201269
[TBL] [Abstract][Full Text] [Related]
4. CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability.
Choi SH; Martinez TF; Kim S; Donaldson C; Shokhirev MN; Saghatelian A; Jones KA
Genes Dev; 2019 Apr; 33(7-8):418-435. PubMed ID: 30819820
[TBL] [Abstract][Full Text] [Related]
5. Mitotic CDK1 and 4E-BP1 II: A single phosphomimetic mutation in 4E-BP1 induces glucose intolerance in mice.
Cao S; Jurczak MJ; Shuda Y; Sun R; Shuda M; Chang Y; Moore PS
PLoS One; 2023; 18(3):e0282914. PubMed ID: 36897840
[TBL] [Abstract][Full Text] [Related]
6. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.
Shuda M; Kwun HJ; Feng H; Chang Y; Moore PS
J Clin Invest; 2011 Sep; 121(9):3623-34. PubMed ID: 21841310
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 4E-BP1 activity in the mammalian oocyte.
Jansova D; Koncicka M; Tetkova A; Cerna R; Malik R; Del Llano E; Kubelka M; Susor A
Cell Cycle; 2017 May; 16(10):927-939. PubMed ID: 28272965
[TBL] [Abstract][Full Text] [Related]
8. Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
Pons B; Armengol G; Livingstone M; López L; Coch L; Sonenberg N; Ramón y Cajal S
Oncol Rep; 2012 Jan; 27(1):225-31. PubMed ID: 21922152
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1).
Heesom KJ; Gampel A; Mellor H; Denton RM
Curr Biol; 2001 Sep; 11(17):1374-9. PubMed ID: 11553333
[TBL] [Abstract][Full Text] [Related]
10. Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice.
Sun R; Guo S; Shuda Y; Chakka AB; Rigatti LH; Zhao G; Ali MAE; Park CY; Chandran U; Yu J; Bakkenist CJ; Shuda M; Moore PS; Chang Y
PLoS One; 2023; 18(5):e0282722. PubMed ID: 37145994
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation.
Kumar V; Pandey P; Sabatini D; Kumar M; Majumder PK; Bharti A; Carmichael G; Kufe D; Kharbanda S
EMBO J; 2000 Mar; 19(5):1087-97. PubMed ID: 10698949
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
14. RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.
Villalonga P; Fernández de Mattos S; Ridley AJ
J Biol Chem; 2009 Dec; 284(51):35287-96. PubMed ID: 19850923
[TBL] [Abstract][Full Text] [Related]
15. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.
Sekiyama N; Arthanari H; Papadopoulos E; Rodriguez-Mias RA; Wagner G; Léger-Abraham M
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4036-45. PubMed ID: 26170285
[TBL] [Abstract][Full Text] [Related]
17. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism.
Greenberg VL; Zimmer SG
Oncogene; 2005 Jul; 24(30):4851-60. PubMed ID: 15897904
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase PPM1G regulates protein translation and cell growth by dephosphorylating 4E binding protein 1 (4E-BP1).
Liu J; Stevens PD; Eshleman NE; Gao T
J Biol Chem; 2013 Aug; 288(32):23225-33. PubMed ID: 23814053
[TBL] [Abstract][Full Text] [Related]
20. The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency.
Magagnin MG; van den Beucken T; Sergeant K; Lambin P; Koritzinsky M; Devreese B; Wouters BG
Proteomics; 2008 Mar; 8(5):1019-28. PubMed ID: 18219697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
